The Role of Botulinum Toxin A Neuromodulator in the Management of Synkinesis in Facial Palsy.

Facial plastic surgery : FPS 2025 Vol.41(3) p. 395-400

Yener A, Acharya V, Andrews P, Meller C, Shamil E

관련 도메인

Abstract

Facial palsy describes the denervation of the facial nerve leading to difficulty in facial animation and expression. Facial synkinesis is the result of complex pathological nerve regeneration following damage to the facial nerve axons. Synkinesis in facial palsy can be managed using facial neuromuscular rehabilitation, botulinum toxin neuromodulators, and surgical treatment options. Botulinum toxin A can be used as an adjunct to other treatment options to manage synkinesis. This article will explore the role of botulinum toxin A in the management of synkinesis in facial palsy including the clinical assessment, injection location (muscles targeted), dosages, treatment interval, and long-term results. It will also include surgical management options.

추출된 의학 개체 (NER)

유형영어 표현한국어 / 풀이UMLS CUI출처등장
시술 botulinum toxin 보툴리눔독소 주사 dict 4
해부 muscles scispacy 1
질환 Palsy C0522224
Paralysed
scispacy 1
질환 synkinesis C0234362
Synkinesis
scispacy 1
기타 Botulinum Toxin A scispacy 1
기타 facial nerve scispacy 1
기타 facial nerve axons scispacy 1
기타 facial neuromuscular scispacy 1

MeSH Terms

Humans; Synkinesis; Botulinum Toxins, Type A; Facial Paralysis; Neuromuscular Agents; Facial Muscles; Facial Nerve

🔗 함께 등장하는 도메인

이 논문이 속한 카테고리와 같은 논문에서 자주 함께 다뤄지는 카테고리들

관련 논문